Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants

Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants

PurposePlasma level of B-type natriuretic peptide (BNP), an emerging, sensitive, and specific biomarker of hemodynamically significant patent ductus arteriosus (PDA), rapidly decreases in infants receiving cyclooxygenase inhibitors for ductal closure. We investigated the usefulness of serial BNP mea...

Full description

Bibliographic Details
Main Authors: Jeonghee Shin, Eun Hee Lee, Jee Hyun Lee, Byung Min Choi, Young Sook Hong
Format: Article
Language:English
Published: Korean Pediatric Society 2017-06-01
Series:Korean Journal of Pediatrics
Subjects:
B-type natriuretic peptide
Ibuprofen
Patent ductus arteriosus
Preterm infant
Online Access:http://kjp.or.kr/upload/pdf/kjped-60-175.pdf

Internet

http://kjp.or.kr/upload/pdf/kjped-60-175.pdf

Similar Items